AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 292: E1231-E1237, 2007. First published December 19, 2006; doi:10.1152/ajpendo.00561.2006
0193-1849/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/4/E1231    most recent
00561.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bruce, C. R.
Right arrow Articles by Kraegen, E. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bruce, C. R.
Right arrow Articles by Kraegen, E. W.

Overexpression of carnitine palmitoyltransferase I in skeletal muscle in vivo increases fatty acid oxidation and reduces triacylglycerol esterification

Clinton R. Bruce,1 Camilla Brolin,1 Nigel Turner,1,2 Mark E. Cleasby,1 Feike R. van der Leij,3,4 Gregory J. Cooney,1,5 and Edward W. Kraegen1,5

1Diabetes and Obesity Research Program, Garvan Institute of Medical Research, Darlinghurst; 2School of Health Sciences, University of Wollongong, Wollongong, New South Wales, Australia; 3Pediatrics Department, University of Groningen, Groningen; 4Unit Life Sciences, Van Hall University of Applied Sciences, Leeuwarden, The Netherlands; and 5St. Vincent's Clinical School, Faculty of Medicine, University of New South Wales, New South Wales, Australia

Submitted 15 October 2006 ; accepted in final form 14 December 2006

A key regulatory point in the control of fatty acid (FA) oxidation is thought to be transport of FAs across the mitochondrial membrane by carnitine palmitoyltransferase I (CPT I). To investigate the role of CPT I in FA metabolism, we used in vivo electrotransfer (IVE) to locally overexpress CPT I in muscle of rodents. A vector expressing the human muscle isoform of CPT I was electrotransferred into the right lateral muscles of the distal hindlimb [tibialis cranialis (TC) and extensor digitorum longus (EDL)] of rats, and a control vector expressing GFP was electrotransferred into the left muscles. Initial studies showed that CPT I protein expression peaked 7 days after IVE (+104%, P < 0.01). This was associated with an increase in maximal CPT I activity (+30%, P < 0.001) and a similar increase in palmitoyl-CoA oxidation (+24%; P < 0.001) in isolated mitochondria from the TC. Importantly, oxidation of the medium-chain FA octanoyl-CoA and CPT I sensitivity to inhibition by malonyl-CoA were not altered by CPT I overexpression. FA oxidation in isolated EDL muscle strips was increased with CPT I overexpression (+28%, P < 0.01), whereas FA incorporation into the muscle triacylglycerol (TAG) pool was reduced (–17%, P < 0.01). As a result, intramyocellular TAG content was decreased with CPT I overexpression in both the TC (–25%, P < 0.05) and the EDL (–45%, P < 0.05). These studies demonstrate that acute overexpression of CPT I in muscle leads to a repartitioning of FAs away from esterification and toward oxidation and highlight the importance of CPT I in regulating muscle FA metabolism.

mitochondria; muscle lipids; substrate metabolism



Address for reprint requests and other correspondence: C. R. Bruce, Cellular & Molecular Metabolism Laboratory, Baker Heart Research Institute, PO Box 6492, St. Kiloa Rd. Central, Victoria 8008, Australia (e-mail: clinton.bruce{at}baker.edu.au)




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. Miura, Y. Kai, Y. Kamei, C. R. Bruce, N. Kubota, M. A. Febbraio, T. Kadowaki, and O. Ezaki
{alpha}2-AMPK activity is not essential for an increase in fatty acid oxidation during low-intensity exercise
Am J Physiol Endocrinol Metab, January 1, 2009; 296(1): E47 - E55.
[Abstract] [Full Text] [PDF]


Home page
ptjournalHome page
L. P Turcotte and J. S Fisher
Skeletal Muscle Insulin Resistance: Roles of Fatty Acid Metabolism and Exercise
Physical Therapy, November 1, 2008; 88(11): 1279 - 1296.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.